You are here

Article info

Article menu
Download PDFPDF
Abstracts
General and Risk Management, Patient Safety (including: medication errors, quality control)
Excess dosing and bleeding events in patients treated with abciximab in acute coronary syndromes

Authors

Citation

de Lorenzo-Pinto A, Cuéllar-Basterrechea B, Bueno-Zamora H, et al
Excess dosing and bleeding events in patients treated with abciximab in acute coronary syndromes
European Journal of Hospital Pharmacy 2012;19:115-116.

Publication history

  • First published March 12, 2012.
Online issue publication 
May 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions